The effect of exogenous gangliosides on matrix metalloproteinase secretion by human glioma cells in vitro

European Journal of Cancer

Volumn 32, Issue 5, 1996, Pages 868-871

  Maidment, S L ^a   Merzak, A ^a   Koochekpour, S ^a   Rooprai, H K ^a   Rucklidge, G J ^b   Pilkington, G J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Ganglioside; Gelatinase; Glioma; Metalloproteinase

Indexed keywords

GANGLIOSIDE; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GD3; GANGLIOSIDE GM1; GANGLIOSIDE GM3; GANGLIOSIDE GT 1B; GELATINASE; MATRIX METALLOPROTEINASE;

ARTICLE; CELL INVASION; CONTROLLED STUDY; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SECRETION;

COLLAGENASES; CULTURE MEDIA, CONDITIONED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GANGLIOSIDES; GELATINASES; GLIOMA; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; TUMOR CELLS, CULTURED;

EID: 0029924975     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00659-1     Document Type: Article

References (34)

1. Liotta LA, Thorgeirsson UP, Garbisa S. Role of collagenases in tumor cell invasion. Cancer Metastasis Rev 1982, 1, 277-288.
2. Liotta LA, Stetler-Stevenson WG. Metalloproteinases and cancer invasion. Semin Cell Biol 1990, 1, 99-106.
3. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB 1991, 5, 2145-2154.
4. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genetics 1990, 6, 121-125.
5. Romanic AM, Madri JA. Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol 1994, 4, 145-156.
6. Ennis BW, Matrisian LM. Matrix degrading metalloproteinases. J Neuro Oncol 1994, 18, 105-109.
7. Yang TT, Hawkes SP. Role of the 21 kDa protein TIMP-3 in oncogenic transformation of cultured chicken fibroblasts. Proc Natl Acad Sci USA 1989, 10676-10680.
8. Fishman PH, Brady RO. Biosynthesis and function of gangliosides. Science 1976, 194, 906-915.
9. Schnaar RL. Glycosphingolipids in cell surface recognition (mini review). Glycobiology 1991, 1, 477-485.
10. Yates AJ, Van Brocklyn J, Saqr HE, Guan Z, Stokes BT, O'Dorisio MS. Mechanisms through which gangliosides inhibit PDGF-stimulated mitogenesis in intact Swiss 3T3 cells: receptor tyrosine phosphorylation, intracellular calcium and receptor binding. Exp Cell Res 1993, 204, 38-45.
11. Hakomori SI. Bifunctional role of glycosphingolipids. J Biol Chem 1990, 265, 18713-18716.
12. Merzak A, Koochekpour S, McCrea S, Roxanis Y, Pilkington GJ. Gangliosides modulate proliferation, migration and invasiveness of human brain tumour cells in vitro. Molec Chem Neuropathol 1995, 24, 121-135.
13. Yates AJ, Thompson DK, Boesel CP, Albrightson C, Hart RW. Lipid composition of human neural tumours. J Lipid Res 1979, 20, 428-436.
14. Yates AJ. Glycolipids and gliomas: a review. Neurochem Pathol 1988, 8, 157-180.
15. Traylor DT, Hogan EL. Gangliosides of human cerebral astrocytomas. J Neurochem 1980, 34, 126-131.
16. Rodden FA, Wiegandt H, Bauer BL. Gangliosides: the relevance of current research to neurosurgery. J Neurosurg 1991, 74, 606-619.
17. Cheresh DA, Harper JR, Schulz G, Reisfield RA. Localisation of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells. Proc Natl Acad Sci USA 1984, 81, 5767-5771.
18. Merzak A, Koochekpour S, Pilkington GJ. Adhesion of human glioma cell lines to fibronectin, laminin, vitronectin and collagen I is modulated by gangliosides in vitro. Cell Adhesion Commun 1995, 3, 27-43.
19. Pilkington GJ. Glioma heterogeneity in vitro: the significance of growth factors and gangliosides. Neuropath Appl Neurobiol 1992, 18, 434-442.
20. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerised substrates. Anal Biochem 1980, 102, 196-202.
21. Koochekpour S, Merzak A, Pilkington GJ. Growth factors and gangliosides stimulate laminin production by human glioma cell lines in vitro. Neurosci Lett 1955, 186, 53-56.
22. Bremer EG, Schlessinger J, Hakomori S. Ganglioside-mediated modulation of cell growth: specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. J Biol Chem 1986, 261, 2434-2440.
23. Weis FMB, Davis RJ. Regulation of epidermal growth factor signal transduction: role of gangliosides. J Biol Chem 1990, 265, 12059-12066.
24. Hanai N, Nores GA, Mcleod C, Torres-Mendes CR, Hakomori S. Ganglioside-mediated modulation of cell growth: specific effects of GM3 and lyso-GM3 in tyrosine phosphorylation of the epidermal growth factor receptor. J Biol Chem 1988, 22, 10915-10921.
25. 2LacCer), acting as a strong promoter for epidermal receptor kinase and as a stimulator for cell growth. J Biol Chem 1988, 263, 6296-6301.
26. Hurtt MR, Moosy J, Donovan-Peluso M, Locker J. Amplification of epidermal growth factor gene in gliomas: histopathology and prognosis. J Neuropath Exp Neurol 1992, 51, 84-90.
27. Van Brocklyn J, Bremer EG, Yates AJ. Gangliosides inhibit platelet derived growth factor stimulated receptor dimerisation in human glioma U-1242MG and Swiss 3T3 cells. J Neurochem 1993, 61, 371-374.
28. Pilkington GJ, Dunan JR, Rogers JP, Clarke TM, Knott JCA. Growth factor modulation of surface ganglioside expression in cloned neoplastic glia. Neurosci Lett 1993, 149, 1-5.
29. Drago J, Reid KL, Bartlett PF. Induction of ganglioside marker A2B5 on cultured cerebellar neural cells by growth factors. Neurosci Lett 1989, 107, 245-250.
30. Matrisian LM, Hogan BLM. Growth factor regulated proteases and extracellular matrix remodeling during mammalian development. Current Topics Developmental Biol 1990, 24, 219-59.
31. Shima I, Sasagari Y, Kusukawa J, et al. Production of matrix metalloproteinase 9 (92 kDa gelatinase) by human oesophageal squamous carcinoma in response to epidermal growth factor. Br J Cancer 1993, 67, 721-727.
32. McMahon SB, Monroe JG. Role of primary response genes in generating cellular responses to growth factors. FASEB J 1992, 6, 2707-2715.
33. Kreutter D, Kim JY, Goldenring JR, et al. Regulation of Protein Kinase C activity by gangliosides. J Biol Chem 1987, 262, 1633-1637.
34. Knott JCA, Edwards AJ, Gullan RW, Clarke TM, Pilkington GJ. A human glioma cell line retaining expression of GFAP and gangliosides, recognised by A2B5 and LB1 antibodies, after prolonged passage. Neuropath Appl Neurobiol 1990, 16, 489-500.